A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers

NCT01115322 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

38

Enrollment

INDUSTRY

Sponsor class

Conditions

Acne Vulgaris

Interventions

DRUG: Tazarotene Foam without irradiation
DRUG: Tazarotene Foam with UVA and UVB irradiation
DRUG: Tazarotene Foam with UVA, UVB, and visible light
DRUG: Vehicle Foam without irradiation
DRUG: Vehicle Foam with UVA and UVB irradiation
DRUG: Vehicle Foam with UVA and UVB and visible light irradiation
DRUG: No Treatment without irradiation
DRUG: No Treatment with UVA and UVB irradiation
DRUG: No Treatment with UVA and UVB and visible light irradiation

Sponsor

Stiefel, a GSK Company

Collaborators

[object Object]